Voglibose 0.3 mg Tablets – VOGONIA 0.3 Tablets
Voglibose 0.3mg Mouth Dissolving
10 x 10 (Blister)
VOGONIA 0.3 Tablets – Effective Postprandial Glucose Management
VOGONIA 0.3 Tablets contain Voglibose 0.3 mg, an advanced alpha-glucosidase inhibitor that provides precise control over post-meal blood sugar levels in Type 2 diabetes.
Key Benefits of Voglibose 0.3 mg Tablets – VOGONIA 0.3 Tablets :
Postprandial Blood Sugar Control: Slows carbohydrate absorption, reducing sugar spikes after meals.
Prevents Complications: Reduces the risk of diabetes-related complications like neuropathy and retinopathy.
Weight Neutral: Maintains metabolic health without promoting weight gain.
Ideal Add-On Therapy: Complements existing diabetic medications for enhanced control.
Well-Tolerated: Minimal side effects ensure high patient compliance.
Indications:
Type 2 Diabetes Mellitus
Postprandial Hyperglycemia
Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.
Related Products
Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate
Proin volutpat vitae libero at tincidunt. Maecenas sapien lectus, vehicula vel euismod sed, vulputate
Efpia Medicine Private Limited is a leading name in India’s pharmaceutical industry, excelling as a Best PCD Pharma Franchise Companies in India. Driven by innovation and quality, we provide a comprehensive portfolio of pharmaceutical products across general and specialized categories, including Gynecology, Dermatology, Orthopedics, Neurology, Ophthalmology, Cardiac-Diabetic care, and Proton Pump Inhibitors (PPIs).
Panchkula (Admin Office)
Plot No 404, Basement, Industrial Area, Phase I, Panchkula (HR) 134113
Mumbai(Corporate Office)
3rd Floor, Tree House, Raghuvanshi Mills, Lower Parel (West), Mumbai – 400013 India
Netherlands (Overseas)
217, Lichstraat, Eindhoven, Netherlands
+91 84278 16268
+91 76967 49025
+91 77174 72766
info@efpia.co.in
efpiamedicine@gmail.com
Copyright © EFPIA 2024. All Rights Reserved.